Cancer TARGETases: DSB repair as a pharmacological target

Pharmacology & Therapeutics
Pounami SamadderLumir Krejci

Abstract

Cancer is a disease attributed to the accumulation of DNA damages due to incapacitation of DNA repair pathways resulting in genomic instability and a mutator phenotype. Among the DNA lesions, double stranded breaks (DSBs) are the most toxic forms of DNA damage which may arise as a result of extrinsic DNA damaging agents or intrinsic replication stress in fast proliferating cancer cells. Accurate repair of DSBs is therefore paramount to the cell survival, and several classes of proteins such as kinases, nucleases, helicases or core recombinational proteins have pre-defined jobs in precise execution of DSB repair pathways. On one hand, the proper functioning of these proteins ensures maintenance of genomic stability in normal cells, and on the other hand results in resistance to various drugs employed in cancer therapy and therefore presents a suitable opportunity for therapeutic targeting. Higher relapse and resistance in cancer patients due to non-specific, cytotoxic therapies is an alarming situation and it is becoming more evident to employ personalized treatment based on the genetic landscape of the cancer cells. For the success of personalized treatment, it is of immense importance to identify more suitable targetable prote...Continue Reading

References

Jun 1, 1993·Clinical Immunology and Immunopathology·J G Schaller
Mar 1, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M R Lieber
Feb 21, 1997·The Journal of Biological Chemistry·R A BambaraL A Henricksen
Sep 1, 1997·Nature Genetics·M D GrayL A Loeb
Jun 10, 1998·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·A ShinoharaT Ogawa
Jul 6, 2000·The Journal of Biological Chemistry·B Li, L Comai
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·H MaackeH W Stürzbecher
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·H Cohen, D A Sinclair
Apr 24, 2001·Genes & Development·P R PrinceR J Monnat
Sep 7, 2001·Genes & Development·R T Abraham
Jan 26, 2002·The Journal of Biological Chemistry·Jochen GenschelPaul Modrich
Feb 12, 2002·Nature Genetics·Ronit I YardenLawrence C Brody
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Chris AllenJac A Nickoloff
Apr 23, 2002·Nature Genetics·Hanne Meijers-HeijboerUNKNOWN CHEK2-Breast Cancer Consortium
May 11, 2002·The Journal of Biological Chemistry·Sung-Ho BaeYeon-Soo Seo
May 25, 2002·Molecular and Cellular Biology·Wonchae ChoeJudith L Campbell
Jun 18, 2002·Science·Niall G HowlettAlan D D'Andrea
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Melanie KucherlapatiRaju Kucherlapati
Nov 21, 2002·Journal of the National Cancer Institute·Ken Garber
Nov 21, 2002·Nature·Luca PellegriniAshok R Venkitaraman
Nov 21, 2002·Human Mutation·Nayanta SodhaRosalind A Eeles
Apr 1, 2003·The Journal of Biological Chemistry·Jeanine A HarriganVilhelm A Bohr
Apr 10, 2003·Journal of Molecular Biology·Erica Friedrich-HeinekenUlrich Hübscher
May 8, 2003·Journal of the National Cancer Institute·Lisa L WangSharon E Plon
Jul 16, 2003·Molecular and Cellular Biology·Elisabeth LarsenArne Klungland

❮ Previous
Next ❯

Citations

Jan 6, 2017·Journal of Cancer Prevention·Azad KumarNilesh Kumar Sharma
Nov 28, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Motoyasu AdachiRyota Kuroki
Mar 23, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joana F CamposSabine Berteina-Raboin
Feb 27, 2019·Current Drug Targets·Yucui Zhao, Siyu Chen
Oct 17, 2017·Molecular Cancer Therapeutics·Elena V EfimovaStephen J Kron

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Anti-cancer Agents in Medicinal Chemistry
Rigu Gupta, Robert M Brosh
Cellular and Molecular Life Sciences : CMLS
Feyruz V Rassool, Alan E Tomkinson
© 2022 Meta ULC. All rights reserved